• 

  The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study. 

  Gnanapragasam, Vincent Jeyaseelan; Bratt, O; Muir, K; Lee, LS; Huang, HH; Stattin, P; Lophatananon, A (BioMed Central, 2018-02-28)

  Purpose: To validate a new 5-tier prognostic classification system to better discriminate cancer specific mortality in men diagnosed with primary non-metastatic prostate cancer. Patients and Methods: We applied a recently ...
• 

  A 3 gene methylation signature is a diagnostic biomarker for Barrett’s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens 

  Chettouh, H; Mowforth, O; Galeano-Dalmau, N; Besawada, N; Ross-Innes, C; MacRae, S; Debiram-Beecham, IO'Donovan, MFitzgerald, Rebecca Clare et al.

  Objective Barrett’s Oesophagus is a premalignant condition that occurs in the context of gastro-oesophageal reflux. However, most Barrett’s cases are undiagnosed because of reliance on endoscopy. We have developed a ...
• 

  Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation. 

  Abubakar, Mustapha; Chang-Claude, Jenny; Ali, H Raza; Chatterjee, Nilanjan; Coulson, Penny; Daley, Frances; Blows, FionaBenitez, JavierMilne, Roger LBrenner, HermannStegmaier, ChristaMannermaa, ArtoRudolph, AnjaSinn, PeterCouch, Fergus JDevilee, PeterTollenaar, Rob AEMSeynaeve, CarolineFigueroa, JonineLissowska, JolantaHewitt, StephenHooning, Maartje JHollestelle, AntoinetteFoekens, RenéeKoppert, Linetta BInvestigators, kConFabBolla, Manjeet KWang, QinJones, Michael ESchoemaker, Minouk JKeeman, RenskeEaston, Douglas FrederickSwerdlow, Anthony JSherman, Mark ESchmidt, Marjanka KPharoah, Paul DavidGarcia-Closas, Montserrat et al. (Wiley-Blackwell, 2018-03)

  Limited epidemiological evidence suggests that the etiology of hormone receptor positive (HR+) breast cancer may differ by levels of histologic grade and proliferation. We pooled risk factor and pathology data on 5,905 HR+ ...
• 

  It's PRIMETIME. Postoperative Avoidance of Radiotherapy: Biomarker Selection of Women at Very Low Risk of Local Recurrence. 

  Kirwan, CC; Coles, CE; Bliss, J; PRIMETIME Protocol Working Group, (Elsevier, 2016-09-01)

  PRIMETIME is funded by Cancer Research UK (Grant number: C17918/A20015). C.E. Coles is supported by the Cambridge National Institute of Health Research Biomedical Research Centre. C.C. Kirwan is supported by a National ...

View more